Page 5 - Stock Movemnet

Nuvama retains Buy on Hyundai India; expects steady growth with EV, hybrids

Nuvama has maintained its 'Buy' rating on Hyundai Motor India shares with a target price of ₹3,200, valuing the stock at 33x Sep-27E core EPS plus ₹119 per share in cash

Paytm set to grow, says Axis Securities; upgrades to 'Buy', stock rises 3%

The analysts believe that large merchant payment providers, including Paytm, are entering a robust earnings growth phase

₹2,500-cr order from BHEL sends Power Mech shares up by 5%; details inside

Power Mech shares gained over 5 per cent after the company announced it had secured a ₹2,500 crore order from Bharat Heavy Electricals Limited (BHEL)

Here's why L&T Finance shares advanced over 2% in trade despite weak market

The northward movement in L&T Finance's share price came on the back of its announcement that it has made the allotment of non-convertible debentures (NCDs) worth ₹1,050 crore

Tata Capital debut: Emkay Global bullish on brand, diversified growth play

The brokerage has initiated coverage on Tata Capital with an 'Add' rating and a September 2026 target price of ₹360, implying a 10 per cent upside over the issue price of ₹326 per share

Here's what drove ACME Solar Holdings shares to a 52-week high in trade

ACME Solar Holdings, which listed on the NSE at ₹251 on November 13, 2024, is now trading 25 per cent above its listing price

Raining dividends on D-Street: 113 stocks go ex-date next week; full list

Here is the complete list of stocks that will trade ex-dividend next week, along with their announcement details and record dates

Here's why Kaynes Technology shares were in focus during today's trade

Shares of Kaynes Technology India have appreciated nearly 8 per cent in the last one month, 64 per cent in the past six months, and 43 per cent over the last one year

Biocon shares gain 2% after USFDA inspection at Bengaluru facility; details

The inspection covered various aspects of operations including drug substance manufacturing units, analytical quality control laboratories, microbiology laboratories, and warehouses

Herbal medicine firm Regencell Bioscience skyrockets 60,000%, stuns market

A Hong Kong-based herbal medicine firm with 12 employees is now worth $39 billion. Why Regencell Bioscience sparked a 60,000% YTD stock surge?

Solar Industries shares gain 5% on Q4 results, dividend call; details here

During Q4FY25, Solar Industries' profit after tax (PAT) climbed 42 per cent year-on-year (Y-o-Y) to ₹346 crore from ₹243 crore reported in the corresponding quarter of the previous fiscal year

Restaurant Brands Asia rallies 9% on Q4 results; check full details here

During the Q4FY25, the company's consolidated net loss reduced to ₹ 60.44 crore from a net loss of ₹ 92.09 crore reported in the corresponding quarter of the previous fiscal year (Q4FY24)

Here's why Lloyds Metals & Engineers shares were buzzing in trade on May 20

The company has has signed PPA for a captive solar project with HR Godavari (HR Godavari) for 16.05 MWp / 10.70 MWac, and a captive solar PPA with HR Godavari for 70 MWp / 50 MWac

Here's what drove Reliance Power shares up by 4% on Monday, May 19

Reliance Power and DHI will jointly develop Bhutan's largest solar power project through a 50:50 venture, with an installed capacity of 500 MW

Zodiac Energy hits 20% upper circuit on Q4 results, dividend call; details

A combined total of nearly 0.34 million equity shares of Zodiac Energy, estimated to be valued at ₹1.1 crore, exchanged hands on the BSE and NSE before the trading was halted for the day

Prism Johnson share price zooms 10% on Q4 numbers; check details here

The northward movement in the company's stock price came following the company announced its financial results for the fourth quarter of 2024-25 (Q4FY25)

Here's why KRN Heat Exchanger shares are buzzing in trade on May 15

KRN Heat Exchanger's wholly owned subsidiary has been granted the incentive of ₹141.72 crore from the Performance Linked Incentive (PLI) Scheme for white goods.

Dynamic Cables hits 20% upper circuit on strong Q4 results, dividend call

The company's board has also recommended final dividend of ₹0.50/- per equity share i.e. 5 per cent per equity share of ₹10 each for the financial year ended March 31, 2025

Lupin shares gain 4% on Tolvaptan Tablets launch in US; details here

Lupin, in a release, said that it holds the exclusive first-to-file status for this product and will have 180-day generic drug exclusivity

Sensex, Nifty log best day in 4 yrs on India-Pak truce, US-China trade deal

Nifty50 climbed 936.80 points to touch a high of 24,944.80-just 56 points shy of the psychological 25,000 mark during intraday deals on Monday